###begin article-title 0
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 124 128 124 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
Treatment with estrogen and progesterone (E+P) mimics the protective effect of parity on mammary tumors in rodents and depends upon the activity of p53. The following experiments tested whether exogenous E+P primes p53 to be more responsive to DNA damage and whether these pathways confer resistance to mammary tumors in a mouse model of Li-Fraumeni syndrome.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 314 318 314 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice that differ in p53 status (Trp53+/+, Trp53+/-, Trp53-/-) were treated with E+P for 14 days and then were tested for p53-dependent responses to ionizing radiation. Responses were also examined in parous and age-matched virgins. The effects of hormonal exposures on tumor incidence were examined in BALB/c-Trp53+/- mammary tissues.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 407 411 407 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 473 477 473 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 481 484 481 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp</italic>
###xml 484 488 484 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 610 614 610 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 680 682 680 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
Nuclear accumulation of p53 and apoptotic responses were increased similarly in the mammary epithelium from E+P-treated and parous mice compared with placebo and age-matched virgins. This effect was sustained for at least 7 weeks after E+P treatment and did not depend on the continued presence of ovarian hormones. Hormone stimulation also enhanced apoptotic responses to ionizing radiation in BALB/c-Trp53+/- mice but these responses were intermediate compared with Trp53+/+ and Trp-/- tissues, indicating haploinsufficiency. The appearance of spontaneous mammary tumors was delayed by parity in BALB/c-Trp53+/- mice. The majority of tumors lacked estrogen receptor (ER), but ER+ tumors were observed in both nulliparous and parous mice. However, apoptotic responses to ionizing radiation and tumor incidence did not differ among outgrowths of epithelial transplants from E+P-treated donors and nulliparous donors.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
Therefore, E+P and parity confer a sustained increase in p53-mediated apoptosis within the mammary epithelium and suppress mammary tumorigenesis, but this effect was not retained in epithelial outgrowths.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 742 743 742 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 56 61 <span type="species:ncbi:9606">women</span>
###xml 451 456 <span type="species:ncbi:9606">women</span>
Breast cancer is the most frequent type of cancer among women in the US and ranks as the second leading cause of cancer death [1]. Reproductive history predicts the potential for breast cancer development. For instance, early menarche or late menopause increases lifetime exposure to estrogen and both are associated with increased breast cancer risk [2,3]. However, a full-term pregnancy early in reproductive life reduces breast cancer incidence in women by up to 50% [4,5]. Pregnancy also reduces the incidence of carcinogen-induced mammary tumors in rodents [6]. Treatment with estrogen and progesterone (E+P) to mimic serum levels during pregnancy is sufficient to reduce the incidence of carcinogen-induced mammary tumors in rodents [7-9].
###end p 11
###begin p 12
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Although E+P can render the mammary epithelium resistant to tumors, the underlying mechanisms mediating the protective effect of parity are unknown. It has been proposed that the bolus of ovarian hormones during pregnancy initiates persistent systemic changes in the parous individual. Reductions in growth hormone and prolactin have been associated with decreased breast cancer risk [10-12]. Serum estrogen is also decreased in parous rodents [13]. These changes in the hypothalamic-hypophysial axis would limit the proliferative stimulus to preneoplastic cells and, therefore, reduce the promotional environment for cancer.
###end p 12
###begin p 13
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
Parity also induces changes within the mammary gland, which may prevent tumors. Pregnancy causes morphological changes, including differentiation of the epithelial tree in preparation for lactation, which could alter tumor susceptibility [14]. However, differentiation alone is not sufficient, because prolactin stimulates morphological differentiation but does not render the mammary gland refractory to carcinogen-induced tumors [15]. In addition to morphological differentiation, pregnancy causes permanent changes in the epithelial cells and stroma of the mammary gland [16-18]. Differential expression of growth-regulatory genes such as amphiregulin, pleiotrophin, insulin-like growth factor-1, and transforming growth factor-beta-3 has been reported in parous mammary tissue [19,20] and may limit carcinogenesis in the mammary epithelium.
###end p 13
###begin p 14
###xml 212 219 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1a </italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1131 1136 1131 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53 </italic>
###xml 554 559 <span type="species:ncbi:9606">women</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 808 813 <span type="species:ncbi:9606">women</span>
While alteration in these growth factor signaling pathways may mediate signals from E+P receptors, the p53 pathway appears to be a crucial downstream effector. Both p53 and its downstream transcriptional target, Cdkn1a (also known as p21/WAF1), are increased in parous and E+P-treated mammary epithelium in response to 7,12-diamethylbenz [a]anthracene [21]. In the absence of p53, the protection afforded by parity or exogenous E+P is lost [22,23]. Exposure to ionizing radiation causes DNA double-strand breaks and is a risk factor for breast cancer in women [24,25]. Furthermore, p53-dependent responses to ionizing radiation are modest in mammary epithelium of nulliparous mice [26] but are enhanced during pregnancy and by treatment with E+P for 3 days [27]. Breast cancer is the most common tumor among women with Li-Fraumeni syndrome, a syndrome associated with heterozygous mutations in the gene encoding p53 protein [28,29], highlighting the important role of p53 in susceptibility to breast cancer. Whether the susceptibility to breast cancer in Li-Fraumeni syndrome is due to increased risk of loss of heterozygosity for TP53 or due to diminished p53 activity is unclear.
###end p 14
###begin p 15
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 355 359 355 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 475 479 475 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 677 682 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 682 686 682 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
In these experiments, we demonstrate that p53-dependent apoptosis is increased by both parity and E+P treatment and that p53 sensitivity is retained after withdrawal of systemic hormones. Hormone-stimulated p53-dependent apoptosis and hormone-induced protection were evident even when p53 activity was reduced because of haploinsufficiency in BALB/c-Trp53+/- mice. Consistent with the increased responsiveness of p53, the latency of spontaneous mammary tumors in BALB/c-Trp53+/- mice was increased among parous mice compared with nulliparous mice. However, neither enhanced p53 responsiveness nor suppression of tumors was retained in outgrowths from hormone-stimulated BALB/c-Trp53+/- mammary epithelium when transplanted into nulliparous hosts.
###end p 15
###begin title 16
Materials and methods
###end title 16
###begin title 17
Animal treatments
###end title 17
###begin p 18
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 322 332 322 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
BALB/c mice used in these experiments were housed in temperature-controlled facilities with a 12-hour alternating day/night light cycle. All mice were of BALB/cMed genetic background and include Trp53+/+, Trp53+/-, and Trp53-/-. All mice were maintained on AIN76A (Harlan Teklad, Madison, WI, USA) soy-free diet and water ad libitum. Six hours prior to sacrifice, animals received either a 5-Gy dose of gamma-irradiation from a cesium-137 source (radiation response) or no gamma-irradiation (spontaneous response). At sacrifice, the stage of estrus was determined by vaginal smear. The fourth mammary glands were harvested, fixed overnight in 10% neutral-buffered formalin, and embedded in paraffin. All animals were maintained in accordance with procedures approved by the Institutional Animal Care and Use Committee (project #25-09-19). The treatment groups for animals are summarized below.
###end p 18
###begin title 19
Neonatal E+P or placebo
###end title 19
###begin p 20
###xml 228 230 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 232 236 <span type="species:ncbi:10090">Mice</span>
At 10 days of age, a single 14-day release pellet containing E+P (0.05 mg 17beta-estradiol and 3 mg progesterone) or placebo (Innovative Research of America, Sarasota, FL, USA) was implanted subcutaneously as outlined in Figure 3a. Mice were returned to their dams and allowed to mature normally. The fourth mammary glands were harvested at 10 weeks of age.
###end p 20
###begin p 21
###xml 88 92 88 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 698 702 698 702 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 864 866 864 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 975 980 975 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 980 984 980 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1024 1028 1024 1028 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 1238 1243 1238 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1243 1247 1243 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1269 1274 1269 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1274 1277 1274 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1348 1353 1348 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1353 1357 1353 1357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1405 1410 1405 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1410 1414 1410 1414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1424 1428 1424 1428 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 1662 1667 1662 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1667 1671 1667 1671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1781 1783 1781 1783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1793 1795 1793 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1836 1841 1836 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">Mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 1484 1488 <span type="species:ncbi:10090">mice</span>
###xml 1596 1600 <span type="species:ncbi:10090">mice</span>
###xml 1721 1725 <span type="species:ncbi:10090">mice</span>
###xml 1886 1891 <span type="species:ncbi:10090">mouse</span>
Responses to irradiation in the mammary epithelium are enhanced by hormonal treatments. (a) The timeline summarizes treatment schedules of mice. Pellets obtained from Innovative Research of America (Sarasota, FL, USA) were used to deliver either E+P to mice for 14 days (neonatal E+P or mature E+P). Placebo groups were implanted with control pellets at these times. Mice were mated starting at 5 weeks of age and nursed pups for 1 week, and then mammary glands were allowed to involute for 4 weeks post-weaning to produce parous females. Tissues were harvested to determine basal levels of p53 and TUNEL labeling or irradiated 6 hours prior to harvest to determine responses following DNA damage. (b) Radiation-induced accumulation of p53 was increased significantly by neonatal E+P and mature E+P compared with the placebo-treated controls. The proportion of p53+ mammary epithelial cells in the E+P-treated groups did not differ from that in parous mice. The tissues from Trp53-/- mice were devoid of immunoreactive p53. (c) Radiation-induced TUNEL labeling also showed significant increases following treatment with neonatal E+P and mature E+P compared with the placebo-treated controls. Radiation-induced apoptosis was diminished in Trp53-/- tissues compared with Trp53+/+. However, the proportion of TUNEL-positive epithelial cells in parous Trp53-/- was increased compared with the placebo-treated Trp53-/- controls. (d) Levels of spontaneous apoptosis were low in nulliparous mice but increased significantly by neonatal E+P and were similar to the levels observed in tissues from parous mice. No significant difference in TUNEL labeling was detected in Trp53-/- tissues from nulliparous and neonatal E+P-treated mice. Bars indicate statistical differences between means: *P < 0.05; **P < 0.01. E+P, estradiol and progesterone; Trp53, transformation-related protein 53 (gene in mouse encoding the p53 tumor suppressor protein); TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 21
###begin title 22
Mature E+P or placebo
###end title 22
###begin p 23
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
At 6 weeks of age, a single 14-day release pellet containing E+P (0.05 mg estradiol and 3 mg progesterone) or placebo (Innovative Research of America) was implanted subcutaneously as outlined in Figure 3a. The fourth mammary glands were harvested at 10 weeks of age.
###end p 23
###begin title 24
Parous and age-matched virgin
###end title 24
###begin p 25
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 303 306 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
At 5 weeks of age, female mice were mated to produce parous females. After parturition, females were permitted to nurse for 7 days and then were force-weaned and allowed to involute for 28 days. At the time of tissue harvest, parous mice were usually between 14 and 15 weeks of age. Age-matched virgin (AMV) mice controls were also collected between 14 and 15 weeks of age. The timeline for treatment of mice is outlined in Figure 3a.
###end p 25
###begin title 26
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Ovariectomized E+P and nulliparous mice
###end title 26
###begin p 27
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 12 16 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 400 402 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
BALB/c-Trp53+/+ mice were hormone-treated as per mature E+P and placebo-treated mice. At approximately 11 weeks of age, mice were ovariectomized. Endogenous ovarian hormones were allowed to clear for 2 weeks. At approximately 13 weeks of age, all mice received a 5-Gy dose of gamma-irradiation 6 hours prior to harvest of the fourth mammary glands. The timeline for the treatments is shown in Figure 4a.
###end p 27
###begin p 28
###xml 93 97 93 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 339 343 339 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 471 473 471 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 482 486 482 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 577 581 577 581 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i) </bold>
###xml 672 676 672 676 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(ii)</bold>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 97 101 <span type="species:ncbi:10090">Mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
Increases in radiation-induced apoptosis are retained in E+P-treated mice after ovariectomy. (a) Mice were treated with E+P or placebo at 6 to 8 weeks of age. At 10 weeks of age, mice were ovariectomized and endogenous hormones were allowed to clear for 2 weeks. All mice received a 5-Gy dose of radiation 6 hours prior to tissue harvest. (b) Radiation-induced apoptosis was increased in mammary tissues from E+P-treated mice compared with the placebo-treated controls (*P < 0.01). (c) TUNEL-positive epithelial cells were minimal in ducts from nulliparous ovariectomized mice (i) but were detected frequently in tissues from mice that were E+P-treated and ovariectomized (ii). All images were taken at x 400. E+P, estradiol and progesterone; IR, ionizing radiation; OVX, ovariectomized; TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 28
###begin title 29
Whole organ culture
###end title 29
###begin p 30
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 12 16 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
BALB/c-Trp53+/+ mice were hormone-treated as per mature E+P or placebo. At 12 weeks of age, the fourth inguinal mammary gland was harvested under aseptic conditions, divided into two portions, and floated on Ferrosan surgifoam sponge (Ethicon Inc., Somerville, NJ, USA) in 2 mL of serum-free phenol-red-free Dulbecco's modified Eagle's medium (DMEM)/F-12 (1:1) media supplemented with insulin as described previously [26,27]. The timeline for treatment of mice and tissues is shown in Figure 5a.
###end p 30
###begin p 31
###xml 92 96 92 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 483 487 483 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 529 537 529 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 665 673 665 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 796 798 796 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 807 811 807 811 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 888 891 888 891 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i)</bold>
###xml 929 933 929 933 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(ii)</bold>
###xml 979 984 979 984 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iii)</bold>
###xml 1022 1026 1022 1026 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iv)</bold>
###xml 1035 1043 1035 1043 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i-iii) </bold>
###xml 1070 1075 1070 1075 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iv) </bold>
###xml 148 152 <span type="species:ncbi:10090">Mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
Radiation-induced apoptosis in the mammary epithelium is not dependent on systemic factors. (a) Timeline for whole organ culture (WOC) experiments. Mice were treated with placebo or E+P at 6 to 8 weeks of age. At tissue harvest, contralateral fourth mammary glands were placed in either serum-free control media or media supplemented with E+P. Mammary glands were maintained in WOC for 3 days followed by a 5-Gy dose of irradiation 6 hours prior to harvesting and fixing the tissue. (b) Mammary glands from mice treated with E+P in vivo had a significantly greater apoptotic response to radiation compared with the placebo-treated controls. The increase due to E+P in vivo was evident regardless of whether the tissues were maintained in serum-free control media or media supplemented with E+P (*P < 0.01). (c) TUNEL-positive staining is shown for placebo-treated glands in control media (i), E+P-treated glands in control media (ii), placebo-treated glands in E+P-treated media (iii), and E+P-treated glands in E+P media (iv). Panels (i-iii) were taken at x 400. Panel (iv) was taken at x 200 to show that TUNEL-positive cells were present throughout all structures of the E+P-treated glands. E+P, estradiol and progesterone; IR, ionizing radiation; TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 31
###begin title 32
Spontaneous tumor study
###end title 32
###begin p 33
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
A total of 44 nulliparous and 52 parous BALB/c-Trp53+/- mice bred in our facility were monitored for up to 74 weeks for the appearance of tumors. Mammary tumor latency was recorded as the week of first detection by palpation.
###end p 33
###begin title 34
Epithelial transplant study
###end title 34
###begin p 35
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 103 107 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a</xref>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 416 422 <span type="species:ncbi:9913">bovine</span>
Donor mammary epithelium was obtained from the fourth mammary glands of 12- to 15-week-old BALB/c-Trp53+/- female mice that were treated as described above: they were treated neonatally with either E+P or placebo and were parous or AMVs. The timelines for treatment of donor mice are summarized in Figure 8a. The tissues were minced, then placed in cryovials containing 1 mL of DMEM/F-12 supplemented with 10% fetal bovine serum and 10% dimethylsulfoxide, and stored in liquid nitrogen until needed for transplantation.
###end p 35
###begin p 36
###xml 94 98 94 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 406 410 406 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 475 479 475 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 611 615 611 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 972 976 972 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1092 1097 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 1026 1029 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 1142 1147 <span type="species:ncbi:10090">mouse</span>
The protective effects of E+P treatment are not retained in epithelial transplant outgrowths. (a) Donor tissues were obtained from Trp53+/- mice that were treated as summarized in the diagram. One group of mice was implanted with pellets containing either no hormones or E+P. Another group of mice was allowed to undergo a full-term pregnancy or remained unmated to provide age-matched nulliparous tissue. (b) Radiation-induced apoptosis was determined in outgrowths of Trp53+/- mammary tissue transplanted into wild-type hosts. The timeline of treatments is summarized graphically in the upper panel. The Trp53+/- mammary tissues from donors, described in panel (a), were transplanted into mammary fat pads of 3-week-old wild-type hosts and allowed to fill the glands. When 10 weeks old, the transplant-bearing hosts were irradiated 6 hours prior to tissue harvest. Radiation-induced apoptosis was low and did not differ among the mammary epithelial outgrowths from Trp53+/- placebo-treated, E+P-treated, age-matched virgin (AMV), or parous mammary tissues. E+P, estradiol and progesterone; Trp53, transformation-related protein 53 (gene in mouse encoding the p53 tumor suppressor protein); TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 36
###begin p 37
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 555 557 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 641 643 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 698 699 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 107 110 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
Fragments (~1 mm3) of hormone-stimulated epithelium (E+P or parous) and nulliparous epithelium (placebo or AMV) were transplanted into contralateral mammary fat pads cleared of endogenous epithelium of the same host mouse as described previously [22]. The transplant epithelium was allowed to fill the fat pad. At 10 weeks of age, one group of mice bearing transplants was subjected to 5 Gy of gamma-irradiation 6 hours prior to tissue harvest for TUNEL (terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling) assay (see timeline in Figure 8b). Another group was subjected to four weekly doses of 1.2 Gy of gamma-irradiation [30] and used for the tumor study (see timeline in Figure 9). Animals in the tumor study were monitored by mammary gland palpation for up to 65 weeks. Tumors were removed when less than 1 cm in diameter to allow the continued monitoring of the contralateral gland. At the end of the tumor study, whole mounts were prepared for all remaining mammary glands to assess outgrowths. Transplant efficiency averaged 83%.
###end p 37
###begin p 38
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 305 309 305 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 752 757 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 757 761 757 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 825 827 825 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 893 898 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">Mice</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
Tumor-free survival in BALB/c mice bearing transplants of Trp53+/- mammary epithelium. Tumor incidence was also determined for outgrowths of Trp53+/- mammary tissue transplanted into wild-type hosts. The timeline of treatments is summarized graphically in the upper panel. Donor mammary tissues from Trp53+/- mice (described in Figure 8a) were transplanted into epithelium-free mammary fat pads of 3-week-old wild-type mice. Beginning at 10 weeks of age, host mice received a 1.2-Gy dose of ionizing radiation once a week for 4 weeks to induce mammary tumors as described previously [30]. Mice were palpated weekly for mammary tumors until 65 weeks old. The incidence and latency of mammary tumors did not differ between epithelial outgrowths from the Trp53+/- mammary tissues from E+P-treated donors and nulliparous donors (P > 0.05). E+P, estradiol and progesterone; IR, ionizing radiation; Trp53, transformation-related protein 53 (gene in mouse encoding the p53 tumor suppressor protein); TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 38
###begin title 39
Histological procedures
###end title 39
###begin title 40
Apoptosis assay
###end title 40
###begin p 41
Four-micrometer paraffin-embedded sections were deparaffinized and subjected to TUNEL using a TdT-FragEL DNA Fragmentation Detection Kit (Calbiochem, now part of EMD Biosciences, Inc., San Diego, CA, USA). Tissues were counterstained with methyl green and analyzed for apoptosis by counting 1,200 cells per slide, with the exception of the whole organ culture, where 600 cells per slide were counted.
###end p 41
###begin title 42
Immunohistochemistry
###end title 42
###begin p 43
Immunohistochemistry was performed on a Dako autostainer (Dako, Carpinteria, CA, USA). After antigen-retrieval and blocking steps, 4-mum sections were incubated with primary antibodies recognizing p53 (CM5; Novacastra, now part of Leica Microsystems, Wetzlar, Germany) (diluted 1:200) or estrogen receptor (ER)-alpha (MC 20; Santa Cruz Biotechnology, Santa Cruz, CA, USA) (diluted 1:200). The signal was amplified using a biotinylated polymer (Vector Laboratories, Burlingame, CA, USA) and detected with diaminobenzidine. Tissues were counterstained with hematoxylin.
###end p 43
###begin title 44
Histopathology
###end title 44
###begin p 45
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
Tumor tissues were fixed overnight in neutral-buffered formalin, processed, and stained with hematoxylin and eosin for histological assessment. The histological evaluations were conducted using the criteria described for genetically engineered mice [31]. Tissues were considered positive for ERalpha nuclear staining similar to or exceeding the intensity observed in normal ducts.
###end p 45
###begin title 46
Whole mount preparation
###end title 46
###begin p 47
Whole mammary glands were fixed in Carnoy's fixative (6:3:1 ethanol/chloroform/glacial acetic acid) and then stained in carmine alum solution (2 g/L carmine; 10 mM aluminum potassium). Glands were dehydrated in graded ethanol, cleared in xylenes, and mounted on slides with permount.
###end p 47
###begin title 48
Microscopy
###end title 48
###begin p 49
A Spot digital camera (Diagnostic Instruments, Sterling Heights, MI, USA) mounted on a Zeiss Axioscope microscope (Carl Zeiss, Jena, Germany) was used to acquire figures. The magnification is noted for each image.
###end p 49
###begin title 50
Statistical analysis
###end title 50
###begin title 51
Quantification of TUNEL and p53
###end title 51
###begin p 52
###xml 346 348 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 405 407 405 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Thresholds for detection were set to determine positive staining for p53 and TUNEL using BIOQUANT Imaging software (BIOQUANT Image Analysis Corporation, Nashville, TN, USA). A total of 1,200 mammary epithelial cells were counted for each specimen, except for whole organ cultures, where 600 cells per specimen were counted. The two-sided Student t test was used to determine differences between groups. A P value of less than 0.05 was considered significantly different. Error bars indicate the standard error of the mean.
###end p 52
###begin p 53
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53 </italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 662 668 662 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53 </italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 392 395 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
Analysis of variance was used to test the effects of Trp53 genotype and hormone treatments on apoptosis. Survival of Trp53-deficient mice was limited in some treatments, due to spontaneous nonmammary tumors that are common in these mice. Nonparametric Kruskal-Wallis and normal theory analysis of variance were performed to determine the reasonableness of pooling data within control groups (AMV, neonatal placebo, mature placebo) and within the hormone-stimulated groups (parous, neonatal E+P, mature E+P). Both the one-way Kruskal-Wallis nonparametric test of medians and the one-way analysis of variance test of means were used to analyze the main effects of Trp53 genotype and hormone treatment as well as the interactions. The Wilcoxon rank sum test was used to examine the significance of differences between means.
###end p 53
###begin title 54
Survival curves
###end title 54
###begin p 55
###xml 275 277 275 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The tumor-free survival data were analyzed using survival distribution with censoring in JMP IN (Duxbury Press, Pacific Grove, CA, USA). The differences in tumor incidences were determined by the chi-square test, and differences were considered statistically significant for P values of less than 0.05.
###end p 55
###begin title 56
Results
###end title 56
###begin title 57
E+P treatment mimics the effects of parity on responses to ionizing radiation
###end title 57
###begin p 58
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1e</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
Treatment with E+P for mature (6 to 8 weeks of age) or neonatal (10 to 24 days of age) mice resulted in lobular-alveolar development along the ductal tree and histological features that were indistinguishable from the glands from parous-involuted mice (Figures 1b and 1e versus 1c and 1f). However, the architecture of mammary glands from E+P-treated and parous mice differs from that of glands of 10-week-old nulliparous mice (Figures 1a and 1d). Therefore, treatment with E+P mimics the effects of parity on mammary gland architecture.
###end p 58
###begin p 59
###xml 116 122 116 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a, d)</bold>
###xml 136 142 136 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b, e)</bold>
###xml 155 162 155 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c, f) </bold>
###xml 195 201 195 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-c) </bold>
###xml 255 260 254 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d-f)</bold>
###xml 282 288 281 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-c) </bold>
###xml 298 303 297 302 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d-f)</bold>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Changes in mammary gland architecture induced by estrogen and progesterone. Tissues from mice that were nulliparous (a, d), E+P-treated (b, e), and parous (c, f) were examined using whole mounts (a-c) and 4-mum sections stained with hematoxylin and eosin (d-f). Magnifications, x 4 (a-c) and x 100 (d-f). E+P, estrogen and progesterone.
###end p 59
###begin p 60
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 649 653 649 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
Prior to ionizing radiation, expression of p53 protein was low in the mammary epithelium. Six hours after ionizing radiation, weak nuclear accumulation of p53 protein was observed in a majority of mammary epithelial cells in tissues from placebo-treated mice (Figures 2C and 2E). In contrast, strong nuclear p53 staining was observed in mammary tissues from mice that had received E+P either during the neonatal period or when mature (Figures 2D and 2F, respectively). Similarly, tissues from age-matched nulliparous mice had lower levels of p53 staining compared with parous mice (Figures 2G and 2H, respectively). The staining is specific as Trp53-/- tissues lacked detectable p53 (Figures 2A and 2B).
###end p 60
###begin p 61
###xml 46 52 46 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-H) </bold>
###xml 66 72 66 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-h) </bold>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 508 513 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 513 517 513 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 571 578 571 578 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A, B) </bold>
###xml 615 622 615 622 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a, b) </bold>
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 695 699 695 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 809 811 809 811 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C</bold>
###xml 813 816 813 816 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E) </bold>
###xml 820 822 820 822 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c</bold>
###xml 824 826 824 826 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e)</bold>
###xml 883 889 883 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G, g)</bold>
###xml 912 914 912 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 988 992 988 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1049 1051 1049 1051 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D</bold>
###xml 1053 1056 1053 1056 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d) </bold>
###xml 1060 1062 1060 1062 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F</bold>
###xml 1064 1066 1064 1066 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f)</bold>
###xml 1127 1133 1127 1133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H, h)</bold>
###xml 1227 1232 1227 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 397 400 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
###xml 1277 1282 <span type="species:ncbi:10090">mouse</span>
Radiation-induced accumulation of p53 protein (A-H) and apoptosis (a-h) in mouse mammary glands. Trp53+/+ mice were treated with placebo or E+P either neonatally (10 to 24 days old) or when mature (6 to 8 weeks) and then were irradiated to examine nuclear accumulation of p53 and TUNEL labeling as indicators of p53 activity. Responses were also examined in mammary tissues from nulliparous mice (AMV = age-matched virgin with parous) and following a full-term pregnancy (parous). The absence of staining in Trp53-/- tissues ensures the specificity of p53 immunostaining (A, B) and p53 dependence of TUNEL staining (a, b) in placebo- and E+P-treated mice, respectively. Mammary glands from Trp53+/+ mice treated with placebo, either neonatally or when mature, exhibited low levels of p53 and TUNEL labeling - (C, E) and (c, e), respectively - and were similar to age-matched virgins (G, g). In contrast, both p53+ nuclei and TUNEL labeling were prevalent in the mammary tissues from Trp53+/+ mice treated with E+P either neonatally or at maturity - (D, d) and (F, f), respectively - and were similar to glands from parous mice (H, h). All images were taken at x 400. E+P, estradiol and progesterone; IHC, immunohistochemistry; Trp53, transformation-related protein 53 (gene in mouse encoding the p53 tumor suppressor protein); TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 61
###begin p 62
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 369 371 369 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 541 543 541 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
For quantification, thresholds were set so that the subset of cells with strong nuclear accumulation were scored as positive. The percentage of cells with p53 accumulation was consistently greater in mammary epithelium following hormonal exposures (Figure 3b). Nuclear accumulation of p53 was more frequent among mice treated neonatally with E+P compared with placebo (P < 0.01). Likewise, p53 expression in the mammary epithelium of mature E+P-treated mice and parous mice was 3- to 4-fold greater than that of mature placebo-treated mice (P < 0.05). There is no statistical difference in expression of p53 protein in the mammary epithelium between neonatally E+P-treated, mature E+P-treated, or parous mice. Likewise, there is no statistical difference in expression of p53 protein between the two placebo groups.
###end p 62
###begin p 63
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2e</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2g</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2d</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2f</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2h</xref>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 643 647 643 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
Apoptosis in the mammary epithelium of placebo-treated, E+P-treated, and parous mice provides a surrogate measure of p53 activity. As for p53, radiation-induced TUNEL-positive nuclei were infrequent in the mammary epithelium of placebo-treated and age-matched virgin mice (Figures 2c, 2e, and 2g) compared with mice treated with E+P or mice that were parous (Figures 2d, 2f, and 2h). The lobular and ductal epithelium appear to be similarly sensitized to apoptosis because TUNEL-positive cells were distributed similarly throughout the gland. These responses were p53-dependent as radiation-induced apoptosis was reduced substantially in Trp53-/- mice (Figures 2a and 2b).
###end p 63
###begin p 64
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 507 511 507 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 597 601 597 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
###xml 739 744 739 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 744 748 744 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 841 846 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 846 850 846 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 979 984 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 984 988 984 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1026 1031 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1031 1035 1031 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1083 1085 1083 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1153 1158 1153 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1158 1162 1158 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1233 1238 1233 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1238 1242 1238 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1246 1251 1246 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1251 1255 1251 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1295 1300 1295 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1300 1304 1300 1304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1411 1413 1411 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3d</xref>
###xml 1464 1469 1464 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1469 1473 1469 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 314 317 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
###xml 1367 1371 <span type="species:ncbi:10090">mice</span>
###xml 1398 1402 <span type="species:ncbi:10090">mice</span>
###xml 1558 1562 <span type="species:ncbi:10090">mice</span>
Apoptotic responses to radiation were increased to similar extents by E+P regardless of whether it was administered neonatally or to mature mice and did not differ from radiation-induced apoptosis detected in parous mice (Figure 3c). The percentage of apoptosis did not differ between the placebo-treated mice and AMV mice, so aging is not a factor in acquiring enhanced apoptotic response to radiation (data not shown). Radiation-induced apoptotic responses in the mammary epithelium from nulliparous Trp53-/- mice were low and not significantly different from the apoptotic response in the Trp53+/+ neonatal placebo or mature placebo, suggesting that p53 response is largely absent in nulliparous mammary tissue (Figure 3c). However, in Trp53-/- parous mammary epithelium, apoptotic response to radiation was significantly greater than in Trp53-/- nulliparous mice, indicating that parity can enhance apoptosis via p53-independent mechanisms. Though elevated, the responses in Trp53-/- parous glands are 2.5-fold lower than Trp53+/+ parous glands (4.0% versus 11.0%, respectively; P < 0.05), indicating that a majority of the response in tissues from Trp53+/+ mice is p53-dependent. Spontaneous apoptosis was also compared for the Trp53+/+ and Trp53-/- genotypes. Basal levels of apoptosis in Trp53+/+ tissues were significantly increased in E+P-treated and parous mice compared with nulliparous mice (Figure 3d). Basal levels of apoptosis were also detected in Trp53-/- tissues, but there was no statistical difference between nulliparous and E+P-treated mice.
###end p 64
###begin p 65
###xml 357 361 <span type="species:ncbi:10090">mice</span>
Both the results for radiation-induced p53 accumulation and TUNEL-positive epithelial cells demonstrate that exposure to E+P results in an increase in p53 responsiveness to radiation that is similar to the effect of parity and that is sustained for at least 7 weeks beyond hormone exposure and that E+P treatment is effective regardless of the age at which mice are treated. The majority of the apoptosis in hormone-stimulated tissues depends on p53, but some p53-independent radiation-induced apoptosis was also detected.
###end p 65
###begin title 66
Enhanced apoptotic responses are retained following withdrawal of estrogen and progesterone
###end title 66
###begin p 67
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4c</xref>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
To test whether endogenous E+P is necessary to maintain the elevated apoptotic responses to radiation in E+P-treated epithelium, nulliparous females were treated with E+P or placebo pellets at 6 to 8 weeks of age (Figure 4a). The mammary tissues were allowed to regress for 2 weeks following the hormone treatments and then the mice were ovariectomized. The mice were allowed to recover for 2 weeks following ovariectomy to clear endogenous hormones. Radiation-induced apoptosis was retained in the E+P-treated mice even after ovariectomy (Figures 4b and 4c). The radiation responses did not differ from ovary-intact animals. These results imply that E+P treatment induces chronic changes in p53-dependent apoptotic responses to ionizing radiation and continued exposure to ovarian hormones is not necessary.
###end p 67
###begin p 68
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 448 456 448 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
To determine whether effects of hormone stimulation were intrinsic to the mammary gland, whole mammary glands from placebo- and E+P-treated mice were cultured in control media or media supplemented with E+P (Figure 5a). Radiation-induced apoptosis in the nulliparous mammary epithelium was low in control media and increased modestly in E+P media (Figures 5b and 5c, i and iii). In contrast, mammary glands from mice that had been treated with E+P in vivo had statistically greater apoptotic response to irradiation in both control and E+P media (Figures 5b and 5c, ii and iv). Thus, increased responsiveness to radiation is intrinsic to hormone-treated mammary tissues and is retained even after removal from systemic influences by placing tissues in whole organ culture.
###end p 68
###begin p 69
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
Taken together, these data demonstrate that E+P-treated mammary glands are primed to be more responsive to irradiation than the nulliparous glands and that this response is independent of the continued presence of ovarian hormones (Figure 4b) or systemic factors (Figure 5b). The high apoptotic response of the E+P-treated glands occurs equally in main branching ducts (Figure 5c, iv) as it does in the lobulo-alveolar structures. Thus, the apoptotic response to irradiation in all of these experiments is not specific to a particular structure within the mature mammary gland.
###end p 69
###begin title 70
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 40 44 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Parity is protective in the BALB/c-Trp53+/- mice
###end title 70
###begin p 71
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 12 16 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53 </italic>
###xml 615 620 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 680 686 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53 </italic>
###xml 795 797 795 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 873 878 873 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 878 882 878 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 926 931 926 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 931 935 931 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 938 943 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 943 947 943 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 1040 1046 1040 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53 </italic>
###xml 1078 1080 1078 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1100 1104 1100 1104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1236 1241 1236 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1241 1245 1241 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 335 338 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
BALB/c-Trp53+/- mice develop spontaneous mammary tumors, providing a model for breast cancer in Li-Fraumeni syndrome [32]. Therefore, we compared the effects of Trp53 genotype and hormonal treatments on radiation-induced apoptosis in mammary tissues. As no differences in responses were detected within the nulliparous control groups (AMV, neonatal placebo, mature placebo) or within the hormone-stimulated groups (parous, neonatal E+P, mature E+P), the data for these groups were pooled (as described in Materials and methods). This was necessary due to the spontaneous nonmammary tumors that are common among the Trp53-deficient mice and limited survival. The overall effect of Trp53 genotype was significant in both the nulliparous control and hormone-stimulated groups (Kruskal-Wallis test, P = 0.04 and 0.002, respectively). In the nulliparous group, responses in the Trp53+/+ mice were significantly greater than either Trp53+/- or Trp53-/- (Figure 6a). Apoptotic responses were also decreased significantly with decreasing dosage of Trp53 in the hormone-stimulated mice (P < 0.05). Thus, Trp53+/- mammary tissue is haploinsufficient with respect to radiation-induced apoptosis, but p53 activity can be increased significantly in Trp53+/- mammary epithelium following hormonal stimulation.
###end p 71
###begin p 72
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 79 83 79 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53 </italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 205 209 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 216 220 216 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 658 660 658 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 670 672 670 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 679 683 679 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 777 781 777 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 892 894 892 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
Effects of hormonal treatments on apoptosis in BALB/c-Trp53+/- mammary glands. (a) Levels of TUNEL-positive mammary epithelium from nulliparous mice were decreased significantly with dosage of Trp53 (Trp53+/+ > Trp53+/- > Trp53-/-) in both nulliparous and hormone-stimulated groups. Data from control groups and hormone-treated groups of mice were pooled to provide sufficient numbers for all genotypes. The nulliparous group represents placebo-treated and age-matched virgins. The hormone-stimulated group represents mammary tissues from mice treated with E+P and parous mice as described in Figure 2a. Bars indicate statistical differences between means: *P < 0.05; **P < 0.01.(b) The incidence of mammary tumors was monitored in both nulliparous and multiparous BALB/c-Trp53+/- female mice. The latency of spontaneous mammary tumors was increased in parous compared with nulliparous mice (P < 0.001). TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 72
###begin p 73
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 188 192 188 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 213 217 213 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 402 404 402 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
To test whether the increased activity of p53 following hormonal stimulation alters tumorigenesis, we compared incidence and latency of spontaneous mammary tumors between nulliparous Trp53+/- mice and parous Trp53+/- mice. Mammary tumors occurred in 43.2% of the nulliparous mice and 34.6% of the parous mice. Mammary tumor-free survival time was increased by 15 weeks in the parous group (Figure 6b) (P < 0.0001). Therefore, parity is effective in protecting from mammary tumors in this mouse model of Li-Fraumeni syndrome.
###end p 73
###begin p 74
###xml 144 149 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 149 153 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 277 278 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 626 627 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 777 778 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 781 783 769 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 816 818 800 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1150 1155 1134 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1155 1159 1139 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1195 1197 1175 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1215 1217 1191 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1159 1163 <span type="species:ncbi:10090">mice</span>
###xml 1376 1380 <span type="species:ncbi:10090">mice</span>
The histopathology and ERalpha status of the tumors were also examined to determine whether parity altered the subtypes of tumors in the BALB/c-Trp53+/- mice. Adenocarcinomas represented the dominant histopathological class of tumors in both nulliparous and parous mice (Table 1) (86.2% and 87.5%, respectively). Although mammary intra-epithelial neoplasias (MINs) are considered precursors of adenocarcinomas, these were a small proportion of tissues because only palpable lesions were collected. Carcinosarcomas and adenosquamous tumors were infrequent. Expression of ERalpha was detected in MIN and adenocarcinomas (Figure 7). Among adenocarcinomas, the proportion positive for ERalpha was increased from 12% among the nulliparous group to 33% among the parous group (Table 1) (P < 0.001). The increase in ERalpha+ tumors may reflect a difference in the cellular origins of the tumors between nulliparous and parous mice. However, this may be confounded with the fact that the mammary tumors in older mice are often collected at an earlier stage of tumor progression because of comorbidities (for example, lymphomas). The mammary tumors in BALB/c-Trp53+/- mice appear to progress from ERalpha+ lesions to ERalpha- tumors (D.J. Jerry, unpublished data). Thus, the difference in ERalpha expression may reflect an earlier stage of progression among mammary tumors from parous mice due to the longer latencies.
###end p 74
###begin p 75
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 127 135 127 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i-iii) </bold>
###xml 146 154 146 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iv-vi) </bold>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 166 170 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 391 395 383 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i) </bold>
###xml 402 404 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 409 414 397 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(ii) </bold>
###xml 421 423 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 443 449 427 433 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iii) </bold>
###xml 456 458 436 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 511 516 491 496 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iv) </bold>
###xml 523 525 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 530 534 506 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(v) </bold>
###xml 541 543 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 563 568 535 540 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(vi) </bold>
###xml 575 577 543 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
Estrogen receptor-alpha expression in spontaneous mammary tumors in Trp53+/- mice. Spontaneous mammary tumors from nulliparous (i-iii) and parous (iv-vi) BALB/c-Trp53+/- mice were stained with anti-ERalpha antibodies. Representative sections are shown for mammary intra-epithelial neoplasias (MIN) and adenocarcinomas that differ in ERalpha status. The tissues from nulliparous mice include (i) ERalpha+ MIN, (ii) ERalpha- adenocarcinoma, and (iii) ERalpha+ adenocarcinoma. The tissues from parous mice include (iv) ERalpha- MIN, (v) ERalpha- adenocarcinoma, and (vi) ERalpha+ adenocarcinoma. Scale bar = 20 mum. ERalpha, estrogen receptor-alpha.
###end p 75
###begin p 76
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 61 65 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Characteristics of spontaneous mammary tumors in BALB/c-Trp53+/- mice
###end p 76
###begin p 77
ERalpha, estrogen receptor-alpha.
###end p 77
###begin title 78
The protective effect of parity and E+P treatment is not retained in epithelial transplants
###end title 78
###begin p 79
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a</xref>
###xml 748 753 748 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 753 757 753 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 841 846 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 846 850 846 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 908 913 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 913 917 913 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 1154 1159 1154 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1159 1163 1159 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1238 1240 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
Parity offers lifetime resistance to mammary tumorigenesis despite the fact that the parous epithelium will go through repeated cycles of proliferation and regression at each estrus cycle and with each pregnancy. Therefore, the protective effect may be programmed into mammary epithelial cells, and specifically mammary epithelial progenitor cells. If this is the case, mammary epithelium from a hormone-stimulated donor transplanted into the cleared fat pad of a nulliparous host should retain protective features. Therefore, we tested whether the apoptotic response to radiation was retained by the epithelial outgrowths that originate from E+P-treated or parous tissue (Figure 8a). There was no difference in radiation-induced apoptosis between Trp53+/- epithelial outgrowths from nulliparous, E+P-treated, or parous donors. Apoptosis in Trp53+/- epithelial outgrowths (Figure 8b) did not differ from the Trp53+/- nulliparous epithelium from glands of ovary-intact mice (Figure 6a). Although E+P treatment enhanced radiation-induced apoptosis in donor tissues (Figure 6a), apoptotic responses to radiation were significantly lower among outgrowths of Trp53+/- mammary epithelium regardless of the treatment of the donor tissue (Figure 8b). Thus, the outgrowths failed to retain the sensitivity to radiation that was present in the donor tissue.
###end p 79
###begin p 80
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 282 286 282 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
To determine whether transplanted epithelium from E+P-treated donors may retain the protective effects of the hormone stimulation after transplantation into the cleared fat pad of nulliparous hosts, we compared tumor incidence and latency between glands bearing transplants of Trp53+/- mammary epithelium from nulliparous versus E+P-treated donor mice. All tumors from the transplanted epithelium, whether E+P-treated or nulliparous, developed adenocarcinomas with similar histopathological features. There was no significant difference in tumor incidence or latency between the epithelium from the E+P-treated donor or the nulliparous donor (Figure 9). Because mammary tumorigenesis is not reduced in the E+P-treated epithelium compared with the nulliparous epithelium and because the radiation-induced apoptotic response is not retained by the hormone-stimulated outgrowths, the parity-induced changes are not a stable phenotype retained by the epithelial progenitor cells that repopulate the gland.
###end p 80
###begin title 81
Discussion
###end title 81
###begin p 82
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 171 175 171 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3d</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 759 763 759 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 793 797 793 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 947 952 947 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 952 956 952 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
The significant role of p53 in tumor suppression in the mammary epithelium was demonstrated by the frequent occurrence of spontaneous tumors in transplants of BALB/c-Trp53-/- mammary epithelium [22]. As p53 protein promotes cell cycle arrest and apoptosis, both can play significant roles in tumor suppression. However, only the proapoptotic function is required to prevent lymphomas whereas the cell cycle checkpoint activity is dispensable [33]. Therefore, enhancement of apoptosis in the mammary epithelium appears to be a critical activity for suppression of tumors. Both radiation-induced and spontaneous apoptosis were enhanced in parous and E+P-treated mammary epithelium (Figures 3c and 3d). As radiation-induced apoptosis was 2.5-fold higher in Trp53+/+ mammary tissues than the Trp53-/- after hormonal stimulation (Figure 6a), the majority of apoptosis is p53-dependent. Though lower in magnitude, apoptosis in the mammary epithelium of Trp53-/- mice was also increased by E+P treatment (Figure 6a). Therefore, in addition to enhancing p53 function, hormonal exposures appear to alter the promotional environment of the host to enhance p53-independent apoptosis pathways [34], both of which may contribute to tumor suppression.
###end p 82
###begin p 83
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Inducible expression of p53 in mouse models has shown that even short-term expression of p53 can substantially delay the appearance of lymphomas and liver carcinomas [35,36]. Therefore, the duration of the enhancement of p53 was of interest. Treatment with E+P for 14 days stimulated changes in the mammary epithelium such that p53-dependent apoptosis in the mammary epithelium persisted even after ovariectomy, indicating that continued exposure to ovarian hormones is not necessary to maintain p53 activity. These results imply that neither the nulliparous nor parous glands are necessarily more vulnerable to genotoxic stress at one phase of the estrus cycle or another. Rather, there is an enhancement of apoptosis that is sustained long after pregnancy and even after cessation of ovarian function.
###end p 83
###begin p 84
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53 </italic>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53</italic>
###xml 492 497 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 497 501 497 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 569 573 569 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 582 586 582 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 612 616 612 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 769 774 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 774 778 774 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 925 930 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53 </italic>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1026 1031 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1031 1035 1031 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1279 1284 1279 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1284 1288 1284 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1301 1303 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 1403 1408 1403 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1408 1412 1408 1412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1576 1581 1576 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1581 1585 1581 1585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1617 1619 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1673 1678 1673 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1678 1682 1678 1682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1690 1692 1690 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 320 325 <span type="species:ncbi:9606">women</span>
###xml 501 506 <span type="species:ncbi:10090">mouse</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 1288 1292 <span type="species:ncbi:10090">mice</span>
###xml 1412 1416 <span type="species:ncbi:10090">mice</span>
Breast cancer is the most common tumor among females with Li-Fraumeni syndrome, which is most often associated with heterozygous mutations in the gene encoding p53 [28], underscoring the prominent role of TP53 in determining breast cancer susceptibility. However, it is not clear whether the risk of breast cancer among women with Li-Fraumeni syndrome is due to reduced activity of p53 or the increased risk of losing the wild-type allele of TP53. As levels of radiation-induced apoptosis in Trp53+/- mouse mammary epithelium were intermediate to the responses in Trp53+/+ and Trp53-/- tissues (Figure 6a), Trp53+/- mammary tissues are haploinsufficient with respect to apoptosis. This intermediate apoptotic response phenotype is consistent with apoptosis observed in Trp53+/- mice during involution of the prostate following castration [37]. Stress responses were also attenuated in HCT116 cells that were heterozygous for TP53 compared with the wild-type cells [38]. Thus, the activity of p53 may fall below a threshold in Trp53+/- mammary epithelium, as proposed by Santarosa and Ashworth [39], to a point that is no longer sufficient to engage appropriate apoptotic responses to genotoxic stress. The appearance of spontaneous mammary tumors was delayed among parous BALB/c-Trp53+/- mice (Figure 6b). Therefore, the activity of p53 is reduced to critical levels in the mammary epithelium of BALB/c-Trp53+/- mice, but hormonal stimulation increases p53-dependent apoptosis and renders the tissue more resistant to tumorigenesis. As parity did not prevent tumors in BALB/c-Trp53-/- mammary epithelial transplants [22], the decrease in mammary tumors among parous BALB/c-Trp53+/- (Figure 6b) appears to be largely p53-dependent.
###end p 84
###begin p 85
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 172 173 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 213 215 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 291 293 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 310 315 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 315 319 307 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 379 381 367 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 427 428 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 438 440 422 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 548 550 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 697 702 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 702 706 682 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 732 734 708 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 752 754 724 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1184 1189 1152 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1189 1193 1157 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 106 111 <span type="species:ncbi:9606">women</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
The mechanism by which E+P sensitizes the p53 pathway is initiated by their respective receptors [27]. In women, the protective effects of parity are limited to the ERalpha+/progesterone receptor-positive tumors [40]. Thus, we investigated whether parity diminished the proportion of ERalpha+ tumors in BALB/c-Trp53+/- mice. In contrast to expectations, the proportion of ERalpha+ tumors was increased among parous mice (Table 1). ERalpha+ mammary tumors were also observed in C57BL/6J mice rendered p53-deficient by inducible deletion by WAP/Cre [41]. However, these results should be interpreted with caution because ERalpha status is confounded with age of mice. Since mammary tumors in BALB/c-Trp53+/- mice progress from ERalpha+ lesions to ERalpha- tumors (K.A. Dunphy, A.C. Blackburn, H. Yan, L.R. O'Connell, D.J. Jerry, unpublished data), the ERalpha expression observed among mammary tumors in parous mice may reflect an earlier stage of progression due to the longer latencies. Additional markers to distinguish basal-like and luminal properties will be needed in order to ascertain whether the cellular origins differ for the mammary tumors in nulliparous and parous BALB/c-Trp53+/- mice.
###end p 85
###begin p 86
###xml 140 141 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 207 209 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 210 212 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 619 621 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 622 624 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 650 655 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 655 659 641 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 802 803 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 922 924 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 967 972 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 972 976 958 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1063 1068 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1068 1072 1054 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1114 1115 1100 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
Decreased expression of ERalpha and increased expression of ERbeta are persistent changes observed in mammary epithelium of parous rodents [8]. ERalpha and ERbeta exert antagonistic effects on p53 activity [42,43]. This could explain the increased p53-dependent apopotosis in hormone-stimulated mammary tissues. Alternatively, the persistent phenotypic changes in ERs and responsiveness of p53 may reflect alterations in the fates of the progenitor cell pool. Indeed, parity-induced mammary epithelial cells have been identified and serve as progenitors of the lobulo-alveolar structures during subsequent pregnancies [44,45]. However, outgrowths of Trp53+/- mammary epithelium from E+P-treated and parous mice failed to retain the elevated apoptotic response to radiation in nulliparous hosts (Figure 9). The characteristics of the outgrowths were not different from nulliparous transplants or nulliparous glands (Figure 6a). Likewise, the outgrowths of E+P-treated Trp53+/- mammary epithelium developed tumors with frequency and latency similar to those of the Trp53+/- transplants from nulliparous mice (Figure 9).
###end p 86
###begin p 87
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
These observations do not preclude the possibility that the fates or number of stem cells may be decreased within the mammary glands of hormone-stimulated mice compared with nulliparous mice. It remains possible that parity decreases the pool of progenitor cells [46] but does not limit the capacity of the stem cells to repopulate upon transplantation. It is equally possible that hormonal stimulation imparts a stable change in the stromal cells and extracellular matrix which modulate p53 function. The extracellular matrix from involuting glands can promote tumors [17,18] but also is essential for differentiation [47,48], and parous stroma decreased the incidence of tumors [49]. Many extracellular matrix proteins change dramatically across developmental phases and can alter integrin-mediated signaling in the mammary gland [19,50,51]. Loss of integrin signaling results in apoptosis in the mammary epithelium [52]. Therefore, hormonal stimulation may result in stable changes within the stroma which limit either tumorigenic transformation of progenitor cells or their progression to invasive tumors.
###end p 87
###begin title 88
Conclusion
###end title 88
###begin p 89
###xml 646 650 <span type="species:ncbi:10090">mice</span>
These results demonstrate that E+P and parity enhance p53-dependent responses to radiation to a similar extent. Increased p53 surveillance and clearance of compromised cells by apoptosis is likely a critical activity that reduces tumors in parous individuals. The heightened sensitivity of p53 is sustained even after withdrawal of ovarian hormones. While the parity-influenced apoptotic mechanism is intrinsic to the mammary gland itself, it is not permanently programmed into the epithelial progenitor cells. Thus, the heightened surveillance of parous mammary epithelium was lost when transplanted into cleared mammary fat pads of nulliparous mice and the transplanted epithelium acquired the tumor incidence of the host. This suggests a mechanism in which the hormones act on the stroma as well as the epithelium to communicate reciprocally to enhance p53-dependent apoptosis.
###end p 89
###begin title 90
Abbreviations
###end title 90
###begin p 91
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53 </italic>
###xml 0 3 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 221 226 <span type="species:ncbi:10090">mouse</span>
AMV = age-matched virgin; E+P = estradiol and progesterone; ER = estrogen receptor; DMEM = Dulbecco's modified Eagle's medium; MIN = mammary intra-epithelial neoplasias; Trp53 = transformation-related protein 53 (gene in mouse encoding the p53 tumor suppressor protein); TUNEL = terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling.
###end p 91
###begin title 92
Competing interests
###end title 92
###begin p 93
The authors declare that they have no competing interests.
###end p 93
###begin title 94
Authors' contributions
###end title 94
###begin p 95
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 172 176 172 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
KAD was responsible for designing and carrying out the bulk of the experiments as well as drafting the manuscript. ACB and HY provided the data on tumor phenotypes in Trp53+/- mice. LRO participated in the transplant studies. DJJ was responsible for the design and coordination of the experiments as well as preparation of the manuscript. All authors read and approved the final manuscript.
###end p 95
###begin title 96
Acknowledgements
###end title 96
###begin p 97
###xml 68 72 <span type="species:ncbi:10090">mice</span>
The authors would like to thank Ellen S Dickinson for providing the mice in our facility, Laurence Sandi for his assistance with surgical procedures, Brooke Bentley for her expert technical assistance in processing mammary tissues and immunohistology, and Carol Bigelow for her assistance with statistical analyses. This work was supported by grants from the US Army Medical Research and Materiel Command (W81XWH0410385 to KAD and DAMD17-01-1-0315 to ACB) and the National Institutes of Health (RO1-CA095164 to DJJ).
###end p 97
###begin article-title 98
Cancer statistics, 2007
###end article-title 98
###begin article-title 99
Estrogen and the risk of breast cancer
###end article-title 99
###begin article-title 100
Oestrogen exposure and breast cancer risk
###end article-title 100
###begin article-title 101
Age at first birth and breast cancer risk
###end article-title 101
###begin article-title 102
Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study
###end article-title 102
###begin article-title 103
###xml 40 44 <span type="species:ncbi:10116">rats</span>
Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy
###end article-title 103
###begin article-title 104
###xml 73 77 <span type="species:ncbi:10116">rats</span>
Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats
###end article-title 104
###begin article-title 105
Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis
###end article-title 105
###begin article-title 106
Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone
###end article-title 106
###begin article-title 107
###xml 44 49 <span type="species:ncbi:9606">women</span>
Elevated levels of prolactin in nulliparous women
###end article-title 107
###begin article-title 108
###xml 50 54 <span type="species:ncbi:10116">rats</span>
Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?
###end article-title 108
###begin article-title 109
Long-term effect of a first pregnancy on the secretion of prolactin
###end article-title 109
###begin article-title 110
###xml 141 145 <span type="species:ncbi:10116">rats</span>
Reproductive experience reduces circulating 17beta-estradiol and prolactin levels during proestrus and alters estrogen sensitivity in female rats
###end article-title 110
###begin article-title 111
Differentiation of the mammary gland and susceptibility to carcinogenesis
###end article-title 111
###begin article-title 112
Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy
###end article-title 112
###begin article-title 113
Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland
###end article-title 113
###begin article-title 114
###xml 34 37 <span type="species:ncbi:10116">rat</span>
The stroma as a crucial target in rat mammary gland carcinogenesis
###end article-title 114
###begin article-title 115
Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis
###end article-title 115
###begin article-title 116
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy
###end article-title 116
###begin article-title 117
Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland
###end article-title 117
###begin article-title 118
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
###end article-title 118
###begin article-title 119
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
###end article-title 119
###begin article-title 120
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis
###end article-title 120
###begin article-title 121
###xml 127 132 <span type="species:ncbi:9606">women</span>
Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women
###end article-title 121
###begin article-title 122
Breast cancer among atomic bomb survivors: relationship of prognosis to pathologic findings
###end article-title 122
###begin article-title 123
Epithelial cell cycling predicts p53 responsiveness to gamma-irradiation during post-natal mammary gland development
###end article-title 123
###begin article-title 124
Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways
###end article-title 124
###begin article-title 125
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers
###end article-title 125
###begin article-title 126
Tumors associated with p53 germline mutations: a synopsis of 91 families
###end article-title 126
###begin article-title 127
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Preferential induction of mammary tumors in p53 hemizygous BALB/c mice by fractionated irradiation of a sub-lethal dose of X-rays
###end article-title 127
###begin article-title 128
###xml 48 52 <span type="species:ncbi:10090">mice</span>
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
###end article-title 128
###begin article-title 129
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice: a model for Li-fraumeni syndrome
###end article-title 129
###begin article-title 130
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Dissecting p53 tumor suppressor functions in vivo
###end article-title 130
###begin article-title 131
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models
###end article-title 131
###begin article-title 132
Modeling the therapeutic efficacy of p53 restoration in tumors
###end article-title 132
###begin article-title 133
###xml 67 73 <span type="species:ncbi:10090">murine</span>
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
###end article-title 133
###begin article-title 134
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Androgen suppressed apoptosis is modified in p53 deficient mice
###end article-title 134
###begin article-title 135
Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency
###end article-title 135
###begin article-title 136
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way
###end article-title 136
###begin article-title 137
Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies
###end article-title 137
###begin article-title 138
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis
###end article-title 138
###begin article-title 139
Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity
###end article-title 139
###begin article-title 140
Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis
###end article-title 140
###begin article-title 141
Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells
###end article-title 141
###begin article-title 142
An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal
###end article-title 142
###begin article-title 143
Pregnancy and the risk of breast cancer
###end article-title 143
###begin article-title 144
New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally
###end article-title 144
###begin article-title 145
###xml 15 18 <span type="species:ncbi:10116">rat</span>
Interaction of rat mammary epithelium with extracellular matrix components
###end article-title 145
###begin article-title 146
Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma
###end article-title 146
###begin article-title 147
Integrins in mammary gland development and differentiation of mammary epithelium
###end article-title 147
###begin article-title 148
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland
###end article-title 148
###begin article-title 149
Growth defects induced by perturbation of beta1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways
###end article-title 149

